Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CPS-immunization for Malaria Antigen Identification
NCT02080026Completed
- Sponsor
- Radboud University Medical Center
- Start
- Jun 2014
- Primary completion
- Jul 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Randomised, open-label trial of Plasmodium falciparum sporozoites in malaria (2 arms), sponsored by Radboud University Medical Center. Primary endpoint: Generation of B-cells for delineation of antibody responses against Plasmodium falciparum pre-erythrocytic stages. Started Jun 2014; status: completed.
02
Drugs
Plasmodium falciparum sporozoites
03
Conditions
malaria
Beyond the preview
Go deeper on NCT02080026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02080026.